Rare anaemias, though individually uncommon, collectively represent a significant public health challenge due to their complexity, diagnostic difficulty, and severe impact on patient quality of life. The rarity and diversity of these conditions often result in delayed diagnosis and suboptimal treatment, underscoring the critical need for heightened awareness, improved diagnostic tools, and innovative therapeutic strategies. The integration of advanced technologies, such as next generation sequencing and artificial intelligence, is not only transforming the diagnostic landscape but also paving the way for more personalized and effective treatments, which are essential for improving outcomes in this underserved patient population. This review provides a comprehensive overview of rare anaemias, emphasizing their classification, advancements in diagnostic methodologies, and evolving therapeutic strategies. It highlights the integration of cutting-edge technologies and the need for equitable access to these advancements to improve outcomes for this underserved patient population.
Author
(s) Details
Joan-Lluis
Vives Corrons
Rare Anaemias and Erythropoietic Disorders Research, Institute for
Leukaemia Research Josep Carreras, Clinical Centre for Ambulatory Medicine, Red
Blood Cell Disorders and Rare Anaemias, Ektacytometry Unit, Còrsega
209.08036-Barcelona, Spain.
Please see the book here:- https://doi.org/10.9734/bpi/psnid/v3/2484
No comments:
Post a Comment